Drug General Information |
Drug ID |
D0B5MZ
|
Former ID |
DNC004612
|
Drug Name |
3-(4-Amino-phenyl)-3-butyl-piperidine-2,6-dione
|
Drug Type |
Small molecular drug
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C15H20N2O2
|
Canonical SMILES |
CCCCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N
|
InChI |
1S/C15H20N2O2/c1-2-3-9-15(10-8-13(18)17-14(15)19)11-4-6-12(16)7-5-11/h4-7H,2-3,8-10,16H2,1H3,(H,17,18,19)
|
InChIKey |
HECRHMWBGLSDHM-UHFFFAOYSA-N
|
PubChem Compound ID |
|
Target and Pathway |
Target(s) |
Cytochrome P450 11A1, mitochondrial |
Target Info |
Inhibitor |
[1]
|
Cytochrome P450 19 |
Target Info |
Inhibitor |
[1]
|
BioCyc Pathway
|
Superpathway of steroid hormone biosynthesis
|
Pregnenolone biosynthesisPWY-7305:Superpathway of steroid hormone biosynthesis
|
Estradiol biosynthesis II
|
Estradiol biosynthesis I
|
KEGG Pathway
|
Steroid hormone biosynthesis
|
Metabolic pathways
|
Ovarian steroidogenesishsa00140:Steroid hormone biosynthesis
|
Ovarian steroidogenesis
|
NetPath Pathway
|
FSH Signaling PathwayNetPath_25:FSH Signaling Pathway
|
PANTHER Pathway
|
Androgen/estrogene/progesterone biosynthesis
|
PathWhiz Pathway
|
SteroidogenesisPW000045:Androgen and Estrogen Metabolism
|
Reactome
|
Endogenous sterolsR-HSA-211976:Endogenous sterols
|
WikiPathways
|
Prostaglandin Synthesis and Regulation
|
Metapathway biotransformation
|
Oxidation by Cytochrome P450
|
Metabolism of steroid hormones and vitamin D
|
Glucocorticoid & Mineralcorticoid Metabolism
|
Corticotropin-releasing hormone
|
Phase 1 - Functionalization of compoundsWP702:Metapathway biotransformation
|
Tryptophan metabolism
|
Ovarian Infertility Genes
|
FSH signaling pathway
|
Integrated Breast Cancer Pathway
|
Phase 1 - Functionalization of compounds
|
References |
REF 1 | J Med Chem. 1986 Aug;29(8):1362-9.Aromatase inhibitors. Synthesis and evaluation of mammary tumor inhibiting activity of 3-alkylated 3-(4-aminophenyl)piperidine-2,6-diones. |